Literature DB >> 2679367

Extended-spectrum beta-lactamases.

A Philippon1, R Labia, G Jacoby.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2679367      PMCID： PMC172613          DOI： 10.1128/AAC.33.8.1131

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  31 in total

1.  Synergy between clavulanic acid and newer beta-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins.

Authors:  S Ben Redjeb; H Ben Yaghlane; A Boujnah; A Philippon; R Labia
Journal:  J Antimicrob Chemother       Date:  1988-02       Impact factor: 5.790

2.  Complete amino acid sequence of p453-plasmid-mediated PIT-2 beta-lactamase (SHV-1).

Authors:  M Barthélémy; J Peduzzi; R Labia
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

3.  Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.

Authors:  A Petit; D L Sirot; C M Chanal; J L Sirot; R Labia; G Gerbaud; R A Cluzel
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

4.  Novel beta-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to beta-lactam antibiotics.

Authors:  R C Spencer; P F Wheat; T G Winstanley; D M Cox; S J Plested
Journal:  J Antimicrob Chemother       Date:  1987-12       Impact factor: 5.790

5.  Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors.

Authors:  M D Kitzis; D Billot-Klein; F W Goldstein; R Williamson; G Tran Van Nhieu; J Carlet; J F Acar; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

6.  Single amino acid substitution between SHV-1 beta-lactamase and cefotaxime-hydrolyzing SHV-2 enzyme.

Authors:  M Barthélémy; J Péduzzi; H Ben Yaghlane; R Labia
Journal:  FEBS Lett       Date:  1988-04-11       Impact factor: 4.124

7.  Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase.

Authors:  D Sirot; J Sirot; R Labia; A Morand; P Courvalin; A Darfeuille-Michaud; R Perroux; R Cluzel
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

8.  Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins.

Authors:  A Bauernfeind; G Hörl
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

Review 9.  Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies.

Authors:  J Sirot; C Chanal; A Petit; D Sirot; R Labia; G Gerbaud
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

10.  Kinetic properties of two plasmid-mediated beta-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins.

Authors:  R Labia; A Morand; K Tiwari; J S Pitton; D Sirot; J Sirot
Journal:  J Antimicrob Chemother       Date:  1988-03       Impact factor: 5.790
View more
  172 in total

1.  TEM-24 produced by four different species of Enterobacteriaceae, including Providencia rettgeri, in a single patient.

Authors:  H Marchandin; C Carriere; D Sirot; H J Pierre; H Darbas
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

Review 2.  Impact of antimicrobial agents and chemotherapy from 1972 to 1998.

Authors:  M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

3.  Outbreak of infection with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Mexican hospital.

Authors:  J Silva; R Gatica; C Aguilar; Z Becerra; U Garza-Ramos; M Velázquez; G Miranda; B Leaños; F Solórzano; G Echániz
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

Review 4.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

5.  Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamases.

Authors:  C C Randegger; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

6.  Contribution of natural amino acid substitutions in SHV extended-spectrum beta-lactamases to resistance against various beta-lactams.

Authors:  C C Randegger; A Keller; M Irla; A Wada; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

7.  Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.

Authors:  Ellen Smith Moland; Jennifer A Black; Jason Ourada; Mark D Reisbig; Nancy D Hanson; Kenneth S Thomson
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

8.  Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.

Authors:  E Vercauteren; P Descheemaeker; M Ieven; C C Sanders; H Goossens
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 9.  Evolution of beta-lactamase inhibitors.

Authors:  D M Livermore
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

10.  Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.

Authors:  P A Bradford; C E Cherubin; V Idemyor; B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.